Get the latest insights on price movement and trends analysis of Neomycin Sulphate in different regions across the world (Asia, Europe, North America, Latin America, and the Middle East & Africa).
Neomycin Sulphate Price Trends for the July-September of 2023
Neomycin Sulphate began its market run with a major slump at the beginning of the third quarter in the Asian markets, particularly China. The veterinary antibiotic drug was experiencing a depressing phase since the production facilities were struggling for a long time in China.
Supplies were long cut short, which made the consuming pharma and biotech sectors shift to other alternative options. So, the neomycin sulphate price index noted a steep fall at the beginning of the first month of the quarter. Even though the following months witnessed some rebound in the neomycin sulphate price trends, the general market outlook was regressive. Overall, low-wavering price trends were observed during the said period.
The European market trends for neomycin sulphate were no different than the Asian trends during the said period of Q3’23, primarily because many European markets are dependent on Asian exports for veterinary drugs like neomycin sulphate. Apart from this, the gradually easing inflationary pressure also took away the upstream cost support. The demand front was also not exciting for neomycin sulphate. So, the general market sentiments remained muted throughout the quarter.
Neomycin Sulphate trade in the American market painted no different picture than the global trends. The price trends were found to be struggling here, too, as the economic situation in the region was still unstable. Overall, a poor market outlook was observed.
According to Procurement Resource, Neomycin Sulphate price analysis offers positive forecasts for the coming months since the depreciated market will look for normalization.
Neomycin Sulphate Price Trends for the First Half of 2023
The prices of neomycin sulphate witnessed a significant incline in the first quarter of 2023 as positive demand from the downstream pharmaceutical and healthcare industries drove the market dynamics.
The bullish trends was also a result of the enhanced interest of international customers, and after the long stretch of covid and the holiday season in China, the consumption, as well as production rates, gained momentum, resulting in northwards movement of the neomycin sulphate prices. However, the second quarter did not follow this path, and from late April, the price trends of neomycin sulphate began to decline. This quarter was further affected by a notable reduction in consumption and a slowing down of manufacturing activities.
The first quarter of 2023 maintained a consistent rise in the prices of neomycin sulphate as the rates of inflation declined along with the cost of energy production. This further improved the trading activities of neomycin sulphate in the region and thus helped the neomycin sulphate prices to move in a positive direction.
Even in the first two months of the second quarter, the limited level of inventories, consistent demand, and slow supply of the products supported the rising cost of neomycin sulphate prices. But in the last month, the rates of inflation started to surge, which in turn caused the cost of energy and interest rates charged by European banks to hike. Further, the depreciation of the Euro in comparison to the US dollar ultimately led to the fall in the price trends of neomycin sulphate.
In the first quarter, the neomycin sulphate market demonstrated strong market movement with a stable rise in the number of orders from the downstream industries, and the price trends of neomycin sulphate inclined. In addition to this, the expensive imports from Asian countries also supported the rise in the price trends.
In the second quarter, many manufacturing units reduced their production activities, putting pressure on the existing level of inventories and supply chains while the demand from the end-user industries remained high, causing the price trends to further incline. But in the last month of the second quarter, the rise in interest rates and overall inflation in North America hampered the growth of neomycin sulphate prices.
According to Procurement Resource, the price trends of Neomycin Sulphate is expected to oscillate in the upcoming quarters as the demand from the downstream industries seems to be sliding amid the weak global economic conditions.
Procurement Resource provides latest prices of Neomycin Sulphate. Each price database is tied to a user-friendly graphing tool dating back to 2014, which provides a range of functionalities: configuration of price series over user defined time period; comparison of product movements across countries; customisation of price currencies and unit; extraction of price data as excel files to be used offline.
Neomycin Sulphate is an antibiotic that is frequently used in veterinary applications that belongs to the aminoglycoside class of antibiotics that is effective in several bacterial infections. It is often used in several formulations such as creams and ointments. It also plays a significant role in the field of biotechnology for cell culture and genetic engineering purposes. This compound helps to study and manipulate gene expression in cells.
|Product Name||Neomycin Sulphate|
|Industrial Uses||Pharmaceutical Manufacturing, Biotechnology, Agriculture, Fisheries|
|Molecular weight||712.72 g/mol|
|Supplier Database||McKesson Corporation, Pfizer Inc, Bausch & Lomb, Perrigo Company, Medimetriks Pharmaceutical, Xgen Pharmaceuticals|
|Region/Countries Covered||Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Iran, Thailand, South Korea, Iraq, Saudi Arabia, Malaysia, Nepal, Taiwan, Sri Lanka, UAE, Israel, Hongkong, Singapore, Oman, Kuwait, Qatar, Australia, and New Zealand
Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece
North America: United States and Canada
Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru
Africa: South Africa, Nigeria, Egypt, Algeria, Morocco
|Currency||US$ (Data can also be provided in local currency)|
|Supplier Database Availability||Yes|
|Customization Scope||The report can be customized as per the requirements of the customer|
|Post-Sale Analyst Support||360-degree analyst support after report delivery|
Note: Our supplier search experts can assist your procurement teams in compiling and validating a list of suppliers indicating they have products, services, and capabilities that meet your company's needs.
The displayed pricing data is derived through weighted average purchase price, including contract and spot transactions at the specified locations unless otherwise stated. The information provided comes from the compilation and processing of commercial data officially reported for each nation (i.e. government agencies, external trade bodies, and industry publications).
Procurement Resource is a one-stop solution for businesses aiming at the best industry insights and market evaluation in the arena of procurement. Our team of market leaders covers all the facets of procurement strategies with its holistic industry reports, extensive production cost and pre-feasibility insights, and price trends dynamics impacting the cost trajectories of the plethora of products encompassing various industries. With the best analysis of the market trends and comprehensive consulting in light of the best strategic footstep, Procurement Resource got all that it takes.
Procurement Resource has made a mark for itself in terms of its rigorous assistance to its clientele. Our experienced panel of experts leave no stone unturned in ensuring the expertise at every step of our clients' strategic procurement journey. Our prompt assistance, prudential analysis, and pragmatic tactics considering the best procurement move for industries are all that sets us apart. We at Procurement Resource value our clients, which our clients vouch for.
Expertise, judiciousness, and expedience are the crucial aspects of our modus operandi at Procurement Resource. Quality is non-negotiable, and we don't compromise on that. Our best-in-class solutions, elaborative consulting substantiated by exhaustive evaluation, and fool-proof reports have led us to come this far, making us the ‘numero uno' in the domain of procurement. Be it exclusive qualitative research or assiduous quantitative research methodologies, our high quality of work is what our clients swear by.